Inventor
HUANG GLENN T
US29 patents
⚠️ This page may combine multiple inventors who share the name “HUANG GLENN T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HUANG GLENN T
14 patentsUS8147865B2Apr 3, 2012
Steroid-containing sustained release intraocular implants and related methods
HUANG GLENN T44 citations98
US8119154B2Feb 21, 2012
Sustained release intraocular implants and related methods
HUANG GLENN T41 citations98
US8440216B2May 14, 2013
Sustained release intraocular implants and related methods
HUANG GLENN T29 citations96
US8293210B2Oct 23, 2012
Sustained release intraocular implants and methods for preventing retinal dysfunction
HUANG GLENN T34 citations95
US8298570B2Oct 30, 2012
Sustained release intraocular implants and related methods
HUANG GLENN T12 citations92
US8263110B2Sep 11, 2012
Sustained release intraocular implants and related methods
HUANG GLENN T13 citations92
US8257730B2Sep 4, 2012
Steroid-containing sustained release intraocular implants and related methods
HUANG GLENN T12 citations92
US8425929B2Apr 23, 2013
Sustained release intraocular implants and methods for preventing retinal dysfunction
HUANG GLENN T25 citations91
US8962009B2Feb 24, 2015
Sustained release intraocular implants and related methods
HUANG GLENN T6 citations84
US8771722B2Jul 8, 2014
Methods of treating ocular disease using steroid-containing sustained release intraocular implants
HUANG GLENN T8 citations84
US9161938B2Oct 20, 2015
Sustained release intraocular implants and methods for treating ocular vasculopathies
HUANG GLENN T6 citations82
US8506986B2Aug 13, 2013
Sustained release intraocular implants and methods for treating ocular vasculopathies
HUANG GLENN T4 citations72
US8715709B2May 6, 2014
Sustained release intraocular implants and methods for treating ocular neuropathies
HUANG GLENN T1 citations52
US8580292B2Nov 12, 2013
Sustained release intraocular implants and methods for treating ocular vasculopathies
HUANG GLENN T0 citations51
Chibi Inc
5 patentsUS11234926B2Feb 1, 2022
Liquid depot for non-invasive sustained delivery of agents to the eye
Chibi Inc4 citations83
US12280141B2Apr 22, 2025
Liquid depot for non-invasive sustained delivery of agents to the eye
Chibi Inc1 citations74
US11497710B2Nov 15, 2022
Eye drop formulation and method for sustained delivery of medicament to the retina
Chibi Inc4 citations72
US12527738B2Jan 20, 2026
Liquid depot for non-invasive sustained delivery of agents to the eye
Chibi Inc0 citations62
US12472142B2Nov 18, 2025
Liquid depot for non-invasive sustained delivery of agents to the eye
Chibi Inc0 citations62
ICON BIOSCIENCE INC
5 patentsUS10799642B2Oct 13, 2020
Dose guides for injection syringe
ICON BIOSCIENCE INC4 citations71
US10159683B2Dec 25, 2018
Use of sustained release dexamethasone in post-cataract surgery inflammation
ICON BIOSCIENCE INC4 citations70
US9636347B2May 2, 2017
Sustained release formulations for the treatment of intraocular pressure or glaucoma
ICON BIOSCIENCE INC0 citations51
US9283231B2Mar 15, 2016
Sustained release formulations for the treatment of intraocular pressure of glaucoma
ICON BIOSCIENCE INC1 citations51
US10028965B2Jul 24, 2018
Use of sustained release dexamethasone in post-cataract surgery inflammation
ICON BIOSCIENCE INC0 citations49
ALLERGAN INC
3 patentsUS9327059B2May 3, 2016
Steroid-containing sustained release intraocular implants and related methods
ALLERGAN INC8 citations84
US10201641B2Feb 12, 2019
Sustained release intraocular implants and methods for treating ocular vasculopathies
ALLERGAN INC1 citations71
US9144543B2Sep 29, 2015
Sustained release intraocular implants and methods for preventing retinal dysfunction
ALLERGAN INC0 citations48